Zealand Pharma A/S ZLDPF Stock
Zealand Pharma A/S Price Chart
Zealand Pharma A/S ZLDPF Financial and Trading Overview
| Zealand Pharma A/S stock price | 49.02 USD |
| Previous Close | 50.82 USD |
| Open | 48.6 USD |
| Bid | 48 USD x 30000 |
| Ask | 49.96 USD x 30000 |
| Day's Range | 48.6 - 48.6 USD |
| 52 Week Range | 35.93 - 83.12 USD |
| Volume | 1K USD |
| Avg. Volume | 2.09K USD |
| Market Cap | 3.41B USD |
| Beta (5Y Monthly) | 0.555 |
| PE Ratio (TTM) | 3.496403 |
| EPS (TTM) | 13.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZLDPF Valuation Measures
| Enterprise Value | -10610027520 USD |
| Trailing P/E | 3.496403 |
| Forward P/E | -41.896553 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.36940503 |
| Price/Book (mrq) | 1.4944041 |
| Enterprise Value/Revenue | -1.148 |
| Enterprise Value/EBITDA | -1.561 |
Trading Information
Zealand Pharma A/S Stock Price History
| Beta (5Y Monthly) | 0.555 |
| 52-Week Change | -30.83% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 83.12 USD |
| 52 Week Low | 35.93 USD |
| 50-Day Moving Average | 47.56 USD |
| 200-Day Moving Average | 63.54 USD |
ZLDPF Share Statistics
| Avg. Volume (3 month) | 2.09K USD |
| Avg. Daily Volume (10-Days) | 130 USD |
| Shares Outstanding | 70.24M |
| Float | 56.67M |
| Short Ratio | N/A |
| % Held by Insiders | 0.53% |
| % Held by Institutions | 51.25% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 69.21% |
| Operating Margin (ttm) | -1585.29% |
| Gross Margin | 99.99% |
| EBITDA Margin | 73.57% |
Management Effectiveness
| Return on Assets (ttm) | 34.72% |
| Return on Equity (ttm) | 56.16% |
Income Statement
| Revenue (ttm) | 9.24B USD |
| Revenue Per Share (ttm) | 131.11 USD |
| Quarterly Revenue Growth (yoy) | 325.00% |
| Gross Profit (ttm) | 9.24B USD |
| EBITDA | 6.8B USD |
| Net Income Avi to Common (ttm) | 6.4B USD |
| Diluted EPS (ttm) | 13.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.47B USD |
| Total Cash Per Share (mrq) | 204.76 USD |
| Total Debt (mrq) | 414M USD |
| Total Debt/Equity (mrq) | 2.86 USD |
| Current Ratio (mrq) | 37.173 |
| Book Value Per Share (mrq) | 32.521324 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.36B USD |
| Levered Free Cash Flow (ttm) | 4.22B USD |
Profile of Zealand Pharma A/S
| Country | United States |
| State | N/A |
| City | Søborg |
| Address | Sydmarken 11 |
| ZIP | 2860 |
| Phone | 45 88 77 36 00 |
| Website | https://www.zealandpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 544 |
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
Q&A For Zealand Pharma A/S Stock
What is a current ZLDPF stock price?
Zealand Pharma A/S ZLDPF stock price today per share is 49.02 USD.
How to purchase Zealand Pharma A/S stock?
You can buy ZLDPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zealand Pharma A/S?
The stock symbol or ticker of Zealand Pharma A/S is ZLDPF.
Which industry does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S industry is Biotechnology.
How many shares does Zealand Pharma A/S have in circulation?
The max supply of Zealand Pharma A/S shares is 70.08M.
What is Zealand Pharma A/S Price to Earnings Ratio (PE Ratio)?
Zealand Pharma A/S PE Ratio is 3.51896620 now.
What was Zealand Pharma A/S earnings per share over the trailing 12 months (TTM)?
Zealand Pharma A/S EPS is 13.93 USD over the trailing 12 months.
Which sector does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S sector is Healthcare.